Mirum Pharmaceuticals, Inc. Liquidation Value

MIRM Other

Cash & Equivalents

$296.68M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $296.68M
Total Obligations: -$215.45M
$81.23M
Per share: $1.57
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $296.68M
AR: $123.33M
Total Obligations: -$215.45M
$204.56M
Per share: $3.94
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $296.68M
AR: $123.33M
Inventory: $24.89M
Total Obligations: -$215.45M
$229.45M
Per share: $4.42
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$81.23M$1.57
Liquid Liquidation Value$204.56M$3.94
Operating Liquidation Value$229.45M$4.42

Key Components (as of 2025-12-31)

Cash & Equivalents$296.68M
Accounts Receivable$123.33M
Inventory$24.89M
Current Liabilities$205.80M
Long-term DebtN/A
Op. Lease Liability$9.65M
Finance LeaseN/A
Shares Outstanding51.9M

Explore all 183 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$296.68M$123.33M$24.89M$9.61M$205.80MN/A$9.65MN/A
2025-09-30$282.02M$107.13M$24.02M$12.17M$160.36MN/A$9.40MN/A
2025-06-30$228.12M$106.84M$22.94M$17.66M$144.80MN/A$9.96MN/A
2025-03-31$211.82M$95.85M$22.42M$11.64M$127.58MN/A$8.65MN/A
2024-12-31$222.50M$78.29M$22.40M$14.62M$126.55MN/A$9.68MN/A
2024-09-30$222.97M$68.53M$21.59M$9.54M$115.75MN/A$9.99MN/A
2024-06-30$233.25M$60.43M$20.44M$9.84M$112.31MN/A$9.32MN/A
2024-03-31$302.84M$55.00M$21.61M$15.98M$105.91MN/A$686,000N/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-02-25 View
2025-09-30 10-Q 2025-11-04 View
2025-06-30 10-Q 2025-08-06 View
2025-03-31 10-Q 2025-05-07 View
2024-12-31 10-K 2025-02-26 View
2024-09-30 10-Q 2024-11-12 View
2024-06-30 10-Q 2024-08-07 View
2024-03-31 10-Q 2024-05-08 View

Community Notes

Loading notes...

Questions

Loading questions...